Jakarta, CNBC Indonesia – The Ministry of State-Owned Enterprises (BUMN) stated that the transformation steps currently being carried out in state-owned companies have become positive sentiment among market players in recent times. Especially the business transformation steps carried out at pharmaceutical SOEs.
BUMN Minister Erick Thohir said this positive response was shown by the purchase of BUMN shares over the last few years, which even exceeded the increase in the LQ45 index.
“What’s interesting … one of the hot ones on the stock exchange is BUMN stocks. 18.7% increase in BUMN shares compared to other stocks on the stock exchange, LQ45 is only 10%,” said Erick in an event on national television, Tuesday. (17/11/2020) evening.
This increase, said Erick, especially occurred in pharmaceutical SOEs in accordance with the development roadmap that these companies would currently undertake.
It was stated that PT Kimia Farma Tbk (KAEF) is preparing to focus on chemical pharmaceuticals and reduce imports of medicinal raw materials in the country. Meanwhile, PT Indofarma Tbk (INAF) will focus on developing herbal medicines.
Meanwhile, the holding company, PT Bio Farma (Persero), will remain in its core business of developing vaccines according to its efforts since the late 1800s. Then cooperation with international institutions was also carried out.
“For how Bio Farma has become the center of Covid vaccine production for the Southeast Asia region, besides we also produce it for our needs,” he added.
(hps / hps)
– .
